Navigation Links
Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems
Date:10/30/2007

The London Clinic Set to Be First in UK to Offer RapidArc(TM) and

Trilogy(R) Treatments

LONDON, Oct. 30 /PRNewswire-FirstCall/ -- The London Clinic is set to be the first UK hospital to offer cancer patients advanced RapidArc(TM) treatments as part of a long-term collaboration with Varian Medical Systems (NYSE: VAR). The London Clinic, one of the UK's most established independent hospitals, will also be the first in the UK to acquire an advanced Trilogy(R) all-in-one linear accelerator.

As part of a 70 million pounds Sterling investment to mark its 75th anniversary, The London Clinic will introduce the radiotherapy services to its patients for the first time when its new state-of-the-art cancer treatment centre is opened in 2009.

As well as the Trilogy accelerator, the hospital has also acquired a second treatment machine -- a Varian Clinac(R) iX linear accelerator -- as well as a full suite of Eclipse(TM) treatment planning software.

Malcolm Miller, Chief Executive of The London Clinic, says: "This latest investment further highlights The London Clinic's long-term commitment to improving cancer care. This new technology will be core to the service offering in our new dedicated cancer treatment centre and will ensure we can provide our cancer patients with the most advanced radiotherapy treatments available.

"Following comprehensive clinical and technical evaluations, we are confident Varian Medical Systems is ideally suited to meet the needs of The London Clinic and our patients."

"As the first hospital in the UK to introduce RapidArc treatments on Trilogy, we will be able to carry out highly conformal 4D image guided radiotherapy that can be delivered
'/>"/>

SOURCE Varian Medical Systems, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. Rice University wins Prestigious Grants from HHMI
4. Developer Of Vaccine For Cancer Granted A Prestigious Fellowship
5. Indian Americans Compete for the Prestigious Spelling Bee Contest
6. Prestigious Wilson Award Goes To Yale Cell Biologist Joel Rosenbaum
7. London Emergency Services Receive Wide Appreciation
8. London Hospital Provides Specialized Care For Pregnant Women
9. Shriners in London Don’t Intend To Give Up Their Caus
10. East London Receives World Class New Private Hospital Facility
11. London: HIV Rates Shoot Up Amongst Drug Users

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...uld aid in development of simple screening test, e...y News) -- In a finding that could lead to a simpl...rchers have identified immune system markers that ... risk for lung cancer. , The researchers examin...137 people with non-small cell lung cancer and a ...
(Date:12/1/2009)...ts that ,less affirming, isolating behaviors jump... 1 (HealthDay News) -- A new study suggests that l...ce others to feel lonely, too. , "Loneliness ca...three degrees of separation," said James H. Fowler... issue of the Journal of Personality and Social P...
(Date:12/1/2009)...L (December 1, 2009)The Clinical Research Building...f Medicine, has been honored for its sustainabilit...signation, established by the U.S. Green Building ...cation Institute (GBCI). LEED is the nation,s pree...eration of green buildings., "Having a LEED certi...
(Date:12/1/2009)..., RESEARCH TRIANGLE PARK, N.C., Dec. 1 /PRNewswir...in 2001 and have expanded over the years serving t... facility which was originally set up in an area o...ervices, as part of the suite of services by Max N...y as a valuable offering. ,, The pharmacy inven...
(Date:12/1/2009)... , ,, NEW YORK, Dec. 1 /PRNewswire/ ...l leader in the development and delivery of custom...ical, scientific and academic markets, will be sho...ch, our first-to-market cross-platform search solu...exicon, based on the American Psychological Associ...
Breaking Medicine News(10 mins):Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Loneliness May Be Catching 2Health News:Loneliness May Be Catching 3Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3
...RPINTERIA, Calif., Dec. 3 Each year during the,ho...and we,re constantly,trying to avoid getting sick....hat have been shown to both enhance the immune sys...sing Vitamin,D, NADH, Ginseng, Astragalus, Glutami...
...cusing on Foot Health Can Prevent High Heel Hangov... the,throbbing and burning you feel after a day or...he good news is, the high heel hangover can be,eli...he shoes they wear can affect their bodies. Not on...
...bot(R) Creamery Cooperative Recipes Are Fit to Cel...e" season,because, well, we feast. But if you,re c...ing the holidays, there is a delicious way to cele...m to,your holiday entertaining menu and help rein ...
... PHILADELPHIA Moms, want your baby to learn to li...earch from the Monell Center, if youre breast feed...ing them yourself. , And, offer your baby plent...ods regardless of whether youre breast feeding or...
...W YORK and PITTSBURGH, Dec. 2 Forest,Laboratories...announced that,Mylan has received an approvable le...DA) in response to its New Drug Application (NDA) ...FDA indicated that a recent inspection of,a backup...
...SHINGTON, Dec. 2 The United States,Conference of ...cognizing,December 1, as World AIDS Day. America,s...d mobilize action to combat the devastating and gr...33 million are now,infected with the deadly HIV vi...
Other Medicine News:Health News:More Energy & Immunity With Vitamin Supplements This Winter 2Health News:High Heel Health 2Health News:Don't Let the Holidays Go to Waist! 2Health News:Don't Let the Holidays Go to Waist! 3Health News:Don't Let the Holidays Go to Waist! 4Health News:How to help baby like fruits and veggies 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 2Health News:FDA Issues Approvable Letter for Nebivolol for the Treatment of Hypertension 3Health News:The United States Conference of Mayors Observes World AIDS Day 2
(Date:12/1/2009)... Codexis, Inc. today announced an ...ts second agreement this year with Teva Pharmaceut...drug manufacturer. The new agreement covers three...ounced an earlier agreement with Teva on January 7...exis biocatalysis technology for key process steps...
(Date:12/1/2009)...re-FirstCall/ -- An expert from PAREXEL Internatio... biopharmaceutical services provider, will lead a ...development in Asia at the Partnerships in Clinica...ber 1-3, 2009 at the Intercontinental Hotel in Sin...ich is focused on maximizing efficiency and mainta...
(Date:11/30/2009)...Newswire/ -- Microban International, Ltd., the glo...ction, is pleased to announce their exclusive Nort...gest U.S. manufacturer and distributor of ceramic ...g two new lines of ceramic tile with OutStand Tech...ng silver based technology, in order to create a l...
Breaking Medicine Technology:Codexis Expands Collaboration with Teva 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2The Help Group Summit on Autism Learning Disabilities and ADHD Features State of the Art Research and Best Practices in Education and Treatment 59028 1The Help Group Summit on Autism Learning Disabilities and ADHD Features State of the Art Research and Best Practices in Education and Treatment 59028 2The Help Group Summit on Autism Learning Disabilities and ADHD Features State of the Art Research and Best Practices in Education and Treatment 59028 3The Help Group Summit on Autism Learning Disabilities and ADHD Features State of the Art Research and Best Practices in Education and Treatment 59028 4The 24th Annual Great Sports Legends Dinner Raises More Than 246 3 Million for the Buoniconti Fund to Cure Paralysis 59026 1The 24th Annual Great Sports Legends Dinner Raises More Than 246 3 Million for the Buoniconti Fund to Cure Paralysis 59026 2The 24th Annual Great Sports Legends Dinner Raises More Than 246 3 Million for the Buoniconti Fund to Cure Paralysis 59026 3Cocoa Research Finds a Place in the Global Health Dialogue 59023 1Cocoa Research Finds a Place in the Global Health Dialogue 59023 2Cocoa Research Finds a Place in the Global Health Dialogue 59023 3Cocoa Research Finds a Place in the Global Health Dialogue 59023 4Cocoa Research Finds a Place in the Global Health Dialogue 59023 5
...f., April 16 ,Pharmacyclics, Inc. (Nasdaq: PCYC )... the anti-tumor activity of PCI-27483, the company...were presented during the,Annual Meeting of the Am...g,held this week in San Diego, CA., Researchers r...tumors,treatment with PCI-27483 led to inhibition ...
...earance, RICHMOND, Va., April 16 Insmed Inc. (Na...d biopharmaceuticals, today,announced that it has ...nes,and Healthcare products Regulatory Agency (MHR...for a follow-on biologic (FOB) product candidate.,...man G-CSF, is a follow-on,biologic of the FDA-appr...
Other Medicine Technology:Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer 2Pharmacyclics' Novel Factor VIIa Inhibitor Demonstrates Potential Inhibition of Tumor Growth in Multiple Types of Cancer 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 2Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 3Insmed Initiates Clinical Study for Follow-on Biologic Version of Neupogen(R) 4
HDL-Cholesterol Direct Reagent
Ammonia Standard
Proteineer™
...XL-I functions over a wide range of concentration,...re thorough characterization than other methods. I...ive change in the distribution of molecular weight...eity, stoichiometry and self-associating systems. ...
Medicine Products: